Sanjivani Paranteral [SANJIVIN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Sanjivani Paranteral Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanjivani Paranteral Ltd. wins in 8 metrics, Divi's Laboratories Ltd. wins in 11 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sanjivani Paranteral Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 25.38 67.11 Sanjivani Paranteral Ltd.
Price-to-Book Ratio 4.60 10.82 Sanjivani Paranteral Ltd.
Debt-to-Equity Ratio 19.66 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.70 4.63 Sanjivani Paranteral Ltd.
EV/EBITDA 19.72 48.63 Sanjivani Paranteral Ltd.
Profit Margin (TTM) 11.23% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 16.37% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 16.37% 29.65% Divi's Laboratories Ltd.
Return on Equity 20.31% 14.64% Sanjivani Paranteral Ltd.
Return on Assets (TTM) 10.35% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-179.46M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -41.38% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 2.79 16.18 Sanjivani Paranteral Ltd.
Enterprise Value $2.17B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.94 15.86 Sanjivani Paranteral Ltd.
Gross Profit Margin (TTM) 33.22% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $61 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $6.60 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) -0.53 0.19 Sanjivani Paranteral Ltd.

Sanjivani Paranteral Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SANJIVIN
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sanjivani Paranteral Ltd.-2.94%-1.27%-8.38%-20.81%-25.53%-35.18%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sanjivani Paranteral Ltd.-41.38%119.73%1,199.55%420.75%341.06%252.00%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Sanjivani Paranteral Ltd. vs Divi's Laboratories Ltd.

MetricSANJIVINDIVISLAB
Market Information
Market Cap i₹2.06B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,743253,443
90 Day Avg. Volume i12,687283,911
Last Close₹143.70₹6,576.50
52 Week Range₹126.00 - ₹268.80₹5,636.50 - ₹7,071.50
% from 52W High-46.54%-7.00%
All-Time High₹396.95 (Dec 30, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-63.80%-7.00%
Growth Metrics
Quarterly Revenue Growth0.27%0.12%
Quarterly Earnings Growth0.43%-0.01%
Financial Health
Profit Margin (TTM) i0.11%0.24%
Operating Margin (TTM) i0.16%0.30%
Return on Equity (TTM) i0.20%0.15%
Debt to Equity (MRQ) i19.660.58
Cash & Liquidity
Book Value per Share (MRQ)₹36.39₹580.95
Cash per Share (MRQ)₹0.56₹122.95
Operating Cash Flow (TTM) i₹35.94M₹19.67B
Levered Free Cash Flow (TTM) i₹80.97M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Sanjivani Paranteral Ltd. vs Divi's Laboratories Ltd.

MetricSANJIVIN (Apr 26, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.3867.11
Forward P/E iN/A53.75
PEG Ratio i0.704.63
Price to Sales (TTM) i2.7916.18
Price to Book (MRQ) i4.6010.82
Market Capitalization
Market Capitalization i₹2.06B₹1.69T
Enterprise Value i₹2.17B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.9415.86
Enterprise to EBITDA i19.7248.63
Risk & Other Metrics
Beta i-0.530.19
Book Value per Share (MRQ) i₹36.39₹580.95

Financial Statements Comparison: Sanjivani Paranteral Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSANJIVIN (2025)DIVISLAB (2025)
Revenue/Sales i695.62M93.25B
Cost of Goods Sold i443.98M38.70B
COGS % of Revenue i63.8%41.5%
Gross Profit i251.64M54.55B
Gross Margin i36.2%58.5%
Research & Development i5.74M270.00M
Operating Income (EBIT) i97.32M25.71B
Operating Margin i14.0%27.6%
EBITDA i113.87M33.19B
EBITDA Margin i16.4%35.6%
Pre-Tax Income i103.52M29.16B
Pre-Tax Income % of Revenue i14.9%31.3%
Income Tax i22.58M7.25B
Income Tax % of Revenue i3.2%7.8%
Net Income (Profit) i80.94M21.91B
Profit Margin i11.6%23.5%

Balance Sheet & Liquidity Metrics

MetricSANJIVIN (2025)DIVISLAB (2025)
Cash & Equivalents i14.85M4.15B
Total Current Assets i341.79M100.81B
Total Current Assets % of Revenue i49.1%108.1%
Total Current Liabilities i317.92M14.52B
Total Current Liabilities % of Revenue i45.7%15.6%
Long-Term Debt i52.89M20.00M
Long-Term Debt % of Revenue i7.6%0.0%
Total Shareholders Equity i398.71M149.69B
Retained Earnings i-427.89M134.00B
Retained Earnings % of Revenue i-61.5%143.7%
Property, Plant & Equipment i386,4203.19B

Cash Flow Statement Comparison

MetricSANJIVIN (2025)DIVISLAB (2025)
Operating Cash Flow i35.94M19.67B
Operating Cash Flow % of Revenue i5.2%21.1%
Capital Expenditures i-303.49M-14.38B
Free Cash Flow i-179.46M2.15B
FCF Margin i-25.8%2.3%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSANJIVINDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.28M265.47M
Float Shares i5.99M117.72M
% Held by Insiders i58.85%52.04%
% Held by Institutions i1.07%28.65%
% Held by Public i40.08%19.31%

Dividend Analysis & Yield Comparison: Sanjivani Paranteral Ltd. vs Divi's Laboratories Ltd.

MetricSANJIVINDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025